Robeco Institutional Asset Management
MRNA icon

Robeco Institutional Asset Management’s Moderna MRNA Stock Holding History

Robeco Institutional Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,345
Closed -$368K – 887
2025
Q2 		$368K Sell
13,345
-17,408
-57% -$458K ﹤0.01% 818
2025
Q1 		$872K Sell
30,753
-1,243
-4% -$44.1K ﹤0.01% 803
2024
Q4 		$1.33M Sell
31,996
-12,015
-27% -$574K ﹤0.01% 755
2024
Q3 		$2.94M Sell
44,011
-46,337
-51% -$4.25M 0.01% 639
2024
Q2 		$10.7M Buy
90,348
+7,500
+9% +$949K 0.02% 412
2024
Q1 		$8.83M Sell
82,848
-11,676
-12% -$1.18M 0.02% 449
2023
Q4 		$9.4M Sell
94,524
-46,304
-33% -$3.89M 0.02% 454
2023
Q3 		$14.5M Sell
140,828
-118,995
-46% -$13.3M 0.04% 369
2023
Q2 		$31.6M Sell
259,823
-22,532
-8% -$3.01M 0.08% 246
2023
Q1 		$43.4M Buy
282,355
+6,674
+2% +$1.1M 0.12% 191
2022
Q4 		$49.5M Buy
275,681
+10,307
+4% +$1.69M 0.14% 166
2022
Q3 		$31.4M Buy
265,374
+9,936
+4% +$1.51M 0.1% 193
2022
Q2 		$36.5M Buy
255,438
+32,177
+14% +$4.6M 0.11% 180
2022
Q1 		$38.5M Buy
223,261
+22,022
+11% +$3.71M 0.09% 225
2021
Q4 		$51.1M Sell
201,239
-50,360
-20% -$14.7M 0.11% 208
2021
Q3 		$96.8M Sell
251,599
-25,126
-9% -$9.27M 0.21% 119
2021
Q2 		$65M Buy
276,725
+95,419
+53% +$17.1M 0.14% 160
2021
Q1 		$23.7M Buy
181,306
+22,615
+14% +$3.28M 0.06% 316
2020
Q4 		$16.6M Buy
158,691
+12,842
+9% +$1.3M 0.04% 366
2020
Q3 		$10.3M Buy
145,849
+22,880
+19% +$1.6M 0.03% 403
2020
Q2 		$7.9M Buy
122,969
+119,138
+3,110% +$6.52M 0.03% 454
2020
Q1 		$115K Buy
+3,831
New +$88.1K ﹤0.01% 926

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Robeco Institutional Asset Management's MRNA Position: Q3 2025 in Review

Robeco Institutional Asset Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 13,345 shares — an estimated $368K sold.

Robeco Institutional Asset Management first reported a position in MRNA in Q1 2020 and held it in 22 quarters. The position peaked at $96.8M in Q3 2021. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Robeco Institutional Asset Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 13,345 Moderna shares in Q3 2025, an estimated $368K.
  • Robeco Institutional Asset Management first reported a position in Moderna in Q1 2020 and held it in 22 quarters.
  • Robeco Institutional Asset Management's Moderna position peaked at $96.8M in Q3 2021.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2025, filed 22 Oct 2025.